Sarkoidose
Sist revidert:
Sist revidert av:Terje Johannessen
Definisjon:
Idiopatisk, granulomatøs systemsykdom som oftest affiserer lunger og intratorakale lymfeknuter, men også ekstratorakale manifestasjoner er hyppige
Forekomst:
Usikre tall, tilstanden er ofte asymptomatisk. Insidens er 5-18 per 100000 per år. Debuterer hyppigst i aldersgruppen 30-55 år
Symptomer:
30-50% er symptomfrie og oppdages ved et tilfeldig rtg. thorax. Symptomatisk sykdom debuterer enten akutt eller smygende. Hoste, tungpusthet, diffuse brystsmerter, ev. slitenhet og sykdomsfølelse
Funn:
Alle organer kan affiseres, men hyppigst lunger, hud, lymfeknuter, lever. Som regel få eller ingen organiske funn
Diagnostikk:
Finnes ingen definitiv diagnostisk test. Røntgen, ev. CT, blodprøver, histologi
Behandling:
Selvhelbredende hos en god del pasienter. Ved progressiv sykdom behandles med kortikosteroider, ev. immunsupprimerende eller biologiske medisiner, ev. transplantasjon
- Soto-Gomez N, Peters JI. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016 May 15;93(10):840-850.
- Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. N Engl J Med. 2021;385(11):1018-1032. PubMed
- Shinn J, Paauw DS. The Management of Sarcoidosis: A Primary Care Approach. Med Clin North Am. 2015;99:1123-48. doi: 10.1016/j.mcna.2015.05.008 DOI
- Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis published correction appears in Nat Rev Dis Primers. 2019 Jul 16;5(1):49. Nat Rev Dis Primers. 2019;5(1):45. PMID: 31273209 PubMed
- Stavem K. Sarkoidose. Norsk legemiddelhåndbok, sist oppdatert 20.07.2020. www.legemiddelhandboka.no
- Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis 1899; 17: 543-50. PubMed
- Norsk sarkoidose forening i samarbeid med Norsk forening for lungemedisin: Faglige retningslinjer for sarkoidose, 2022. Oversatt fra Svensk Lungmedicinsk Förenings Vårdprogram för Sarkoidos 2014 (oppdatert 2018 og 2021). Oversetter: Trond Bjørge. Språklig gjennomgang: Karin Saastad-Rühl. sarkoidose.no
- King TE. Clinical manifestations and diagnosis of pulmonary sarcoidosis. UpToDate, last updated Mar 24, 2022. www.uptodate.com
- Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018; 9(11): 227-240. pmid:30364496 PubMed
- Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014 Mar 29;383(9923):1155-67. pmid: 24090799 PubMed
- King TE. Treatment of pulmonary sarcoidosis: Initial therapy with glucocorticoids. UpToDate, last updated Jan 25, 2017. UpToDate
- Voortman M, Drent M, Baughman RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol. 2019;32(3):475-483. PMID: 30865007 PubMed
- Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323.
- Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart 2021. doi:10.1136/heartjnl-2019-316442 DOI
- Sohn D-W, Park J-B. Cardiac sarcoidosis. Heart 2023. pmid:36631144 PubMed
- Brown F, Modi P, Tanner LS. Lofgren Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 1, 2022.
- Sand M, Sand D, Thrandorf C. Cutaneous lesions of the nose. Head Face Med 2010. pmid:20525327 PubMed
- Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis. Clinical review. BMJ 2009; 339: b3206. BMJ (DOI)
- Tan JL, Fong HK, Birati EY, Han Y. Cardiac Sarcoidosis. Am J Cardiol. 2019;123(3):513-522. PMID: 30503798 PubMed
- Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol 2020;11:1443-1443. PubMed
- Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung 2016; 194:91. PubMed
- Thillai M, Atkins CP, Crawshaw A, et al. BTS Clinical Statement on pulmonary sarcoidosis. Thorax 2021; 76:4. PubMed
- Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43(6):404–411.
- von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309(23):2457–2464.
- Eurelings LEM, Miedema JR, Dalm VASH, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One. 2019;14(10):e0223897. Published 2019 Oct 17. doi:10.1371/journal.pone.0223897 DOI
- Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive care for patients with sarcoidosis. J Clin Med 2020;9:390-390. PubMed
- Saketkoo LA, Russell AM, Jensen K, et al. Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes. Diagnostics (Basel) 2021;11:1089-1089. PubMed
- Drent M, Costabel U, Crouser ED, Grunewald J, Bonella F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med 2021;9:816-818. PubMed
- Kamangar N. Sarcoidosis. Medscape, last updated Jun 20, 2019. emedicine.medscape.com
- Pawate S. Sarcoidosis and the Nervous System. Continuum (Minneap Minn). 2020;26(3):695-715. PMID: 32487903 PubMed
- Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev 2020;29:190146-190146. PubMed
- Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402. PMID: 29625772 PubMed
- Muthiah MP, Gamal AE. Sarcoidosis. BMJ Best Practice, last updated 28 Mar 2018. bestpractice.bmj.com
- Pande A, Culver DA. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med 2020;14:285-298. PubMed
- Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79-92. PubMed
- Al-Kofahi K, Korsten P, Ascoli C, et al. Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag. 2016;12:1623-1634. Published 2016 Nov 7. PMID: 27853374 PubMed
- Yang SJ, Salek S, Rosenbaum JT. Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med. 2017;23(5):458-467. PubMed
- Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1–15.
- Ungprasert P, Crowson CS, Matteson EL. Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. Eur Respir J. 2017. PMID: 28182567 PubMed
- Rossides M, Kullberg S, Askling J et al. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J 2018. pmid:29467203 PubMed
- Terje Johannessen, professor i allmennmedisin, Trondheim
- Peter Jost, spesialist i allmennmedisin, redaktør NEL, Trondheim
Tidligere fagmedarbeidere
- Hasse Melbye, spesialist i allmennmedisin, førsteamanuensis ved institutt for samfunnsmedisin, Universitetet i Tromsø
- Helge Bjørnstad Pettersen, overlege/førsteamanuensis, Lungeavdelingen, Regionsykehuset i Trondheim og Norges Teknisk Naturvitenskapelige Universitet, Trondheim